Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity.
|
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
fd6nwLvQ3uNewGeD